Glycobiology Advance Access originally published online on July 21, 2005
Glycobiology 2005 15(12):1320-1331; doi:10.1093/glycob/cwj014
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Agrin binds
-synuclein and modulates
-synuclein fibrillation
2 Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707; 3 Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064; and 4 Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15261
1 To whom correspondence should be addressed; e-mail: gcole{at}nccu.edu
Received on May 2, 2005; revised on June 28, 2005; accepted on July 11, 2005
Recent studies have begun to investigate the role of agrin in brain and suggest that agrins function likely extends beyond that of a synaptogenic protein. Particularly, it has been shown that agrin is associated with the pathological lesions of Alzheimers disease (AD) and may contribute to the formation of ß-amyloid (Aß) plaques in AD. We have extended the analysis of agrins function in neurodegenerative diseases to investigate its role in Parkinsons disease (PD).
-Synuclein is a critical molecular determinant in familial and sporadic PD, with the formation of
-synuclein fibrils being enhanced by sulfated macromolecules. In the studies reported here, we show that agrin binds to
-synuclein in a heparan sulfate-dependent (HS-dependent) manner, induces conformational changes in this protein characterized by ß-sheet structure, and enhances insolubility of
-synuclein. We also show that agrin accelerates the formation of protofibrils by
-synuclein and decreases the half-time of fibril formation. The association of agrin with PD lesions was also explored in PD human brain, and these studies shown that agrin colocalizes with
-synuclein in neuronal Lewy bodies in the substantia nigra of PD brain. These studies indicate that agrin is capable of accelerating the formation of insoluble protein fibrils in a second common neurodegenerative disease. These findings may indicate shared molecular mechanisms leading to the pathophysiology in these two neurodegenerative disorders.
Key words:
agrin
/
heparan sulfate proteoglycan
/
Parkinsons disease
/
protein conformational disorders
/
-synuclein
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Nadanaka and H. Kitagawa Heparan Sulphate Biosynthesis and Disease J. Biochem., July 1, 2008; 144(1): 7 - 14. [Abstract] [Full Text] [PDF] |
||||
